Zobrazeno 1 - 10
of 93
pro vyhledávání: '"H SHEMIRANI"'
Publikováno v:
Journal of Research in Medical Sciences, Vol 10, Iss 5, Pp 292-297 (2005)
Background: Many patients with suspected acute myocardial infarction (AMI) and eligible for thrombolytic therapy may not be treated because of association between hemorrhagic complications especially intracranial hemorrhage (ICH), and severe hyperten
Externí odkaz:
https://doaj.org/article/2a4ceedefd8f411583d162d9ce33074c
Publikováno v:
Journal of Research in Medical Sciences, Vol 9, Iss 4, Pp 173-177 (2004)
Background: The risk for unsuccessful reperfusion after streptokinase therapy may be caused by the antifibrinolytic effect of platelet-derived type 1 plasminogen activator inhibitor (Pal-1) and antistreptokinase antibodies. This study aims to show th
Externí odkaz:
https://doaj.org/article/cfb16f36b9c442b9b6e483ef2aa0fe30
Autor:
H SHEMIRANI, M POORMOGHADDAS
Publikováno v:
Journal of Research in Medical Sciences, Vol 7, Iss 4 (2002)
Introduction. Renovascular disease is the commonset form of surgically curable hypertension Estimates of the prevalence in general population range from 0.2 percent to 4 percent. It is the most common secondary form of hypertension that is not easily
Externí odkaz:
https://doaj.org/article/1b1c7dd337ee40c09cfdd7b765c23efb
Publikováno v:
Journal of Research in Medical Sciences, Vol 6, Iss 3 (2001)
Introduction. Although common theraputic methods for myocardial infarction are conducted, mortality and morbidity of this disease are high, yet. Therefore, finding a new economical therapies such as metabolic modulation of ischemic myocardial muscle
Externí odkaz:
https://doaj.org/article/57c66d17845c4483a1777d0f33b0cd04
Publikováno v:
Journal of Research in Medical Sciences, Vol 5, Iss 2 (2000)
Introduction. Antistreptokinase antibodies in sera of individuals with previous streptococcal infection might theoretically influence the thrombolytic activity of streptokinase. Streptokinase as the only thrombolytic drug is used in MI management in
Externí odkaz:
https://doaj.org/article/225b02a8c3b449baa361918b3142b8e6
Publikováno v:
Platelets, Vol 30, Iss 2, Pp 139-147 (2019)
The purpose of this study was to evaluate the association between platelet (PLT) count and mean platelet volume (MPV) and venous thromboembolism (VTE). Thus, this study reviewed and performed a quantitative synthesis on data from the literature. This
Externí odkaz:
https://doaj.org/article/ac36e6bee43b45a09c178d43d656b6a9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Farzaneh Sadeghi, Ferenc Sarkady, Katalin S. Zsóri, István Szegedi, Rita Orbán-Kálmándi, Edina G. Székely, Nikolett Vasas, Ervin Berényi, László Csiba, Zsuzsa Bagoly, Amir H. Shemirani
Publikováno v:
Journal of personalized medicine. 12(8)
Ischemic stroke is one of the leading causes of death and disability. An inflammatory response is observed in multiple stages of cerebral ischemia, particularly in the acute phase. Recent publications revealed that neutrophil-lymphocyte ratio (NLR) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d37a1fd2b3a0afb48bca59aad7e7335
https://pubmed.ncbi.nlm.nih.gov/35893315
https://pubmed.ncbi.nlm.nih.gov/35893315
Autor:
Muszbek, Réka Bogáti, Éva Katona, Amir H. Shemirani, Enikő Balogh, Helga Bárdos, Viktória Jeney, László
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 10; Pages: 5845
Plasma factor XIII (pFXIII) is a heterotetramer of FXIII-A and FXIII-B subunits. The cellular form (cFXIII), a dimer of FXIII-A, is present in a number of cell types. Activated FXIII (FXIIIa), a transglutaminase, plays an important role in clot stabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::affa4b30e0e86b337e45581eb8df5b46
Autor:
Réka, Bogáti, Éva, Katona, Amir H, Shemirani, Enikő, Balogh, Helga, Bárdos, Viktória, Jeney, László, Muszbek
Publikováno v:
International journal of molecular sciences. 23(10)
Plasma factor XIII (pFXIII) is a heterotetramer of FXIII-A and FXIII-B subunits. The cellular form (cFXIII), a dimer of FXIII-A, is present in a number of cell types. Activated FXIII (FXIIIa), a transglutaminase, plays an important role in clot stabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0c3600a582d6331d5b42761a20dd728e
https://pubmed.ncbi.nlm.nih.gov/35628664
https://pubmed.ncbi.nlm.nih.gov/35628664